CCES 2019 CCES vs Stavros Katsantonis

In April 2019 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the football player Stavros Katsantonis after his sample tested positive for the prohibited substance
Selective androgen receptor modulators (SARMs) LGD-4033.

After notification the Athlete waived his right for a hearing, accepted the violation, the provisional suspension and the sanction proposed by CCES.
Therefore the CCES decides on 21 May 2019 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 18 April 2019.

Original document

2019 CCES decision Stavros Katsantonis (S).pdf

Parameters

Legal Source
National Decisions
Date
21 May 2019
Original Source
Canadian Centre for Ethics in Sport (CCES)
Country
Canada
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Admission
Intent
Period of ineligibility
Waiver of "right to be heard"
Sport/IFs
American Football (IFAF) - International Federation of American Football
Other organisations
Canadian Centre for Ethics in Sport (CCES)
Canadian University Sports (U Sports)
Laboratories
Montreal, Canada: Laboratoire de controle du dopage INRS-Institut Armand-Frappier
Doping classes
S1. Anabolic Agents
Substances
LGD-4033 (ligandrol)
Selective androgen receptor modulators (SARMs)
Document type
Pdf file
Date generated
4 June 2019
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin